Bendamustine and rituximab: Complete response in a 62-year-old female with an aggressive lymphoma and an ejection fraction of 20%

Taha Alrifai*, Kelly Grant Szymanski, Parameswaran Venugopal, Brett Mahon, Tochukwu Okwuosa, Reem Karmali

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Bendamustine and rituximab: Complete response in a 62-year-old female with an aggressive lymphoma and an ejection fraction of 20%'. Together they form a unique fingerprint.

Medicine & Life Sciences